Sigma Healthcare Limited (ASX:SIG)
Australia flag Australia · Delayed Price · Currency is AUD
2.900
0.00 (0.00%)
Aug 19, 2026, 4:11 PM AEST

Sigma Healthcare Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, Sigma Healthcare stock has a consensus rating of "Buy" and an average price target of $3.30. The average 1-year stock price forecast is 13.79% higher than the current stock price, while the lowest is $2.60 (-10.34%) and the highest is $3.90 (+34.48%).

Price Target: $3.30 (+13.79%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$2.60$3.30$3.35$3.90
Change-10.34%+13.79%+15.52%+34.48%
* Price targets were last updated on Jul 20, 2026.

Analyst Ratings

The average analyst rating for Sigma Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy688888
Buy323333
Hold433445
Sell111000
Strong Sell000000
Total141415151516

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Bell Potter
Bell Potter
Hold
Maintains
$3.00
HoldMaintains$3.00+3.45%Jul 20, 2026
Citi
Citi
Hold
Maintains
$3.20
HoldMaintains$3.20+10.34%Jul 16, 2026
RBC Capital
RBC Capital
Hold
Maintains
$2.60
HoldMaintains$2.60-10.34%Jul 13, 2026
Unknown Analyst
Macquarie
No rating
Macquarie
Buy
Maintains
$3.50
BuyMaintains$3.50+20.69%Jul 12, 2026
Morgan Stanley
Morgan Stanley
Buy
Maintains
$3.20
BuyMaintains$3.20+10.34%Jun 10, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
10.88B
from 6.00B
Increased by 81.31%
Revenue Next Year
12.08B
from 10.88B
Increased by 10.99%
EPS This Year
0.06
from 0.06
Increased by 17.32%
EPS Next Year
0.08
from 0.06
Increased by 18.49%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingJun 30, 2021Jun 30, 2022Jun 30, 2023Jun 30, 2024Jun 30, 2025Jun 30, 2026
Revenue
2.42B2.99B3.09B3.29B6.00B10.88B
Revenue Growth
-3.48%23.67%3.27%6.59%82.18%81.31%
Gross Profit
668.30M1.07B917.70M1.04B1.44B1.98B
Gross Margin
27.62%35.83%29.69%31.66%24.00%18.19%
Operating Income
-69.53M574.54M428.73M552.65M769.21M1.10B
Net Income
-175.98M385.93M304.33M541.01M529.91M728.58M
EPS
----0.060.06
EPS Growth
-----17.32%
Forward PE
----50.6844.92
Dividend / Share
----0.010.04
Free Cash Flow
1.38B140.63M367.65M48.92M-187.60M781.68M
No. Analysts
-----16
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.

Revenue Forecast

Revenue202620272028
High11.0B
Avg10.9B
Low10.6B

Revenue Growth

Revenue Growth202620272028
High
84.0%
Avg
81.3%
Low
77.2%

EPS Forecast

EPS202620272028
High0.07
Avg0.06
Low0.06

EPS Growth

EPS Growth202620272028
High
27.2%
Avg
17.3%
Low
9.0%